These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 19888725)

  • 1. Structural properties of pore-forming oligomers of alpha-synuclein.
    Kim HY; Cho MK; Kumar A; Maier E; Siebenhaar C; Becker S; Fernandez CO; Lashuel HA; Benz R; Lange A; Zweckstetter M
    J Am Chem Soc; 2009 Dec; 131(47):17482-9. PubMed ID: 19888725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The aggregation and fibrillation of alpha-synuclein.
    Fink AL
    Acc Chem Res; 2006 Sep; 39(9):628-34. PubMed ID: 16981679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid-state NMR reveals structural differences between fibrils of wild-type and disease-related A53T mutant alpha-synuclein.
    Heise H; Celej MS; Becker S; Riedel D; Pelah A; Kumar A; Jovin TM; Baldus M
    J Mol Biol; 2008 Jul; 380(3):444-50. PubMed ID: 18539297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural evidence for alpha-synuclein fibrils using in situ atomic force microscopy.
    Zhang F; Ji LN; Tang L; Hu J; Hu HY; Xu HJ; He JH
    Acta Biochim Biophys Sin (Shanghai); 2005 Feb; 37(2):113-8. PubMed ID: 15685368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The lipid peroxidation metabolite 4-oxo-2-nonenal cross-links alpha-synuclein causing rapid formation of stable oligomers.
    Näsström T; Wahlberg T; Karlsson M; Nikolajeff F; Lannfelt L; Ingelsson M; Bergström J
    Biochem Biophys Res Commun; 2009 Jan; 378(4):872-6. PubMed ID: 19070597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxic prefibrillar α-synuclein amyloid oligomers adopt a distinctive antiparallel β-sheet structure.
    Celej MS; Sarroukh R; Goormaghtigh E; Fidelio GD; Ruysschaert JM; Raussens V
    Biochem J; 2012 May; 443(3):719-26. PubMed ID: 22316405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary structure of alpha-synuclein oligomers: characterization by raman and atomic force microscopy.
    Apetri MM; Maiti NC; Zagorski MG; Carey PR; Anderson VE
    J Mol Biol; 2006 Jan; 355(1):63-71. PubMed ID: 16303137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
    Meredith SC
    Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Forcing nonamyloidogenic beta-synuclein to fibrillate.
    Yamin G; Munishkina LA; Karymov MA; Lyubchenko YL; Uversky VN; Fink AL
    Biochemistry; 2005 Jun; 44(25):9096-107. PubMed ID: 15966733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of different regions of alpha-synuclein in the assembly of fibrils.
    Qin Z; Hu D; Han S; Hong DP; Fink AL
    Biochemistry; 2007 Nov; 46(46):13322-30. PubMed ID: 17963364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceleration of alpha-synuclein aggregation by homologous peptides.
    Du HN; Li HT; Zhang F; Lin XJ; Shi JH; Shi YH; Ji LN; Hu J; Lin DH; Hu HY
    FEBS Lett; 2006 Jun; 580(15):3657-64. PubMed ID: 16764865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seed-dependent accelerated fibrillation of alpha-synuclein induced by periodic ultrasonication treatment.
    Kim HJ; Chatani E; Goto Y; Paik SR
    J Microbiol Biotechnol; 2007 Dec; 17(12):2027-32. PubMed ID: 18167451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein array analysis of oligomerization-induced changes in alpha-synuclein protein-protein interactions points to an interference with Cdc42 effector proteins.
    Schnack C; Danzer KM; Hengerer B; Gillardon F
    Neuroscience; 2008 Jul; 154(4):1450-7. PubMed ID: 18541383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A triple-emission fluorescent probe reveals distinctive amyloid fibrillar polymorphism of wild-type alpha-synuclein and its familial Parkinson's disease mutants.
    Celej MS; Caarls W; Demchenko AP; Jovin TM
    Biochemistry; 2009 Aug; 48(31):7465-72. PubMed ID: 19586054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyrroloquinoline quinone (PQQ) prevents fibril formation of alpha-synuclein.
    Kobayashi M; Kim J; Kobayashi N; Han S; Nakamura C; Ikebukuro K; Sode K
    Biochem Biophys Res Commun; 2006 Oct; 349(3):1139-44. PubMed ID: 16962995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review: formation and properties of amyloid-like fibrils derived from alpha-synuclein and related proteins.
    El-Agnaf OM; Irvine GB
    J Struct Biol; 2000 Jun; 130(2-3):300-9. PubMed ID: 10940234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assembly of alpha-synuclein fibrils in nanoscale studied by peptide truncation and AFM.
    Zhang F; Lin XJ; Ji LN; Du HN; Tang L; He JH; Hu J; Hu HY
    Biochem Biophys Res Commun; 2008 Apr; 368(2):388-94. PubMed ID: 18230346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linker histone H1 binds to disease associated amyloid-like fibrils.
    Duce JA; Smith DP; Blake RE; Crouch PJ; Li QX; Masters CL; Trounce IA
    J Mol Biol; 2006 Aug; 361(3):493-505. PubMed ID: 16854430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural characterization of the intrinsically unfolded protein beta-synuclein, a natural negative regulator of alpha-synuclein aggregation.
    Bertoncini CW; Rasia RM; Lamberto GR; Binolfi A; Zweckstetter M; Griesinger C; Fernandez CO
    J Mol Biol; 2007 Sep; 372(3):708-22. PubMed ID: 17681539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of fibrillation process of alpha-synuclein at the initial stage.
    Tashiro M; Kojima M; Kihara H; Kasai K; Kamiyoshihara T; Uéda K; Shimotakahara S
    Biochem Biophys Res Commun; 2008 May; 369(3):910-4. PubMed ID: 18329380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.